21 CFR 3, 4, 11, 210/211, 820, ICH Q7 - Combination Product Master
|
21 CFR 4 - cGMP for Combination Products
|
21 CFR 11 - Electronic Records with Scope & Application
|
21 CFR 11 - Electronic Records with Scope & Application and Part 11 Checklist
|
21 CFR 11 - Electronic Records with Scope & Application and Preambles
|
21 CFR 11 - with Scope & Appl. & Computerized Systems used in Clinical Investigations
|
21 CFR 11, 101, 110, 117, 120, 123 - GMPs for Fish Industry with Food Labeling
|
21 CFR 11, 110, 111 and 117 - Food and Supplement GMPs
|
21 CFR 11, 110, 117, 120 - Food GMPs
|
21 CFR 11, 110, 117, 120, 123 - GMPs for Fish Industry
|
21 CFR 11, 111 - Electronic Records with Dietary Supplement GMPs
|
21 CFR 11, 203, 205 - PDMA with Electronic Records
|
21 CFR 11, 210/211 - Electronic Records with Drug GMPs
|
21 CFR 11, 210/211 - Electronic Records with Drug GMPs-ENGLISH/SPANISH
|
21 CFR 11, 210/211 - Electronic Records with Drug GMPs-SPANISH
|
21 CFR 11, 210/211 with Keyword Index
|
21 CFR 11, 210/211, 606, 820 - Electronic Record, Drug, Blood & Device
|
21 CFR 11, 210/211, 700/701 - Cosmetic with "Is It Soap or a Drug"
|
21 CFR 11, 210/211, 820 - Electronic Records with Drug and Device GMPs
|
21 CFR 11, 210/211, 820 - Electronic Records with Drug and Device GMPs -ENGLISH/SPANISH
|
21 CFR 11, 210/211, 820 - Electronic Records with Drug and Device GMPs-SPANISH
|
21 CFR 11, 210/211, 820 with Audit Checklists - GMP Auditor’s Basic Handbook
|
21 CFR 11, 210/211, 820, ICH Q7 - Good Manufacturing Practice Handbook
|
21 CFR 11, 50, 54, 56, 312, 314, ICH E2A, E6(R2) - Good Clinical Practice Handbook
|
21 CFR 11, 50, 54, 56, 807, 812, 814, 820, 510K & PMA - Medical Device Master2
|
21 CFR 11, 58 - Electronic Records with Scope & App. and GLP
|
21 CFR 11, 58, 210/211, 600, 601, 610, 820 - Multi-US GMPs
|
21 CFR 11, 58, 210/211, 820 - Master GMP Trainer
|
21 CFR 11, 58, 210/211, 820, ICH E6(R2) - GMP 2 Combination
|
21 CFR 11, 58, 820 - Electronic Records with GLP and QSR
|
21 CFR 11, 606 - Electronic Systems with Blood Industry GMPs
|
21 CFR 11, 820 - Electronic Records with Quality Systems Regulations
|
21 CFR 11, 820 QSR and 830 UDI
|
21 CFR 13 - Public Hearing
|
21 CFR 50 - Protection of Human Subjects
|
21 CFR 50, 54, 56 - GCP Drug Approval Handbook
|
21 CFR 54 - Financial Disclosure by Clinical Investigators
|
21 CFR 56 - Institutional Review Boards
|
21 CFR 58 - Good Laboratory Practice
|
21 CFR 58, 606 - Good Laboratory Practice for Blood Industry
|
21 CFR 58, 820 - GLP and QSR
|
21 CFR 101, 110 and 117 - Food Labeling Combination
|
21 CFR 106, 107, 110 and 117 - Infant Formula Regulations
|
21 CFR 108, 110, 113, 114 and 117 - GMPs for Low-Acid Foods
|
21 CFR 110, 117, 130, 131, 133 - Milk and Dairy
|
21 CFR 111 - Dietary Supplement handbook
|
21 CFR 112 Produce for Human Consumption
|
21 CFR Part 112 Produce and 117 Food GMPs
|
21 CFR 115 and 118 Egg Products
|
21 CFR 200 - General Drug
|
21 CFR 200, 201 - General Drug & Drug Labeling Combination
|
21 CFR 203 - Prescription Drug Marketing
|
21 CFR 205 - Guidelines for Licensing of Wholesale Drug
|
21 CFR 210/211 - Drug GMPs
|
21 CFR 210/211 - Drug GMPs-ENGLISH/SPANISH
|
21 CFR 210/211 - Drug GMPs-SPANISH
|
21 CFR 210/211 with Drug Preambles
|
21 CFR 210/211 with GMP Audit Check List
|
21 CFR 210/211 with Keyword Index
|
21 CFR 312 - Investigational New Drug Application
|
21 CFR 312, 314, 511 - Human and Animal Drug Approval
|
21 CFR 314 - Applications for FDA Approval to Market a New Drug
|
21 CFR 316 - Orphan Drugs
|
21 CFR 320 - Bioavailability and Bioequivalence Requirements
|
21 CFR 507 - cGMP, Hazard Analysis, and Risk-Based Preventive Controls
|
21 CFR 600 - Biological Products: General
|
21 CFR 600, 601, 610 - Biologic GMP
|
21 CFR 601 - Licensing - Biologics
|
21 CFR 606 - Blood Industry
|
21 CFR 610 - General Biological Products Standards
|
21 CFR 640 - Add. Standards for human blood and blood products
|
21 CFR 660 - Add. Standards for Diagnostic Substances for Lab. Tests
|
21 CFR 680 - Additional Standards for Miscellaneous Products
|
21 CFR 801 - Labeling - Medical Device
|
21 CFR 803 - Medical Device Reporting
|
21 CFR 806 - Medical Devices; Reports of Corrections and Removal
|
21 CFR 807 - Estab. Reg. and Device Listing for Manufacturers and Initial Importers of Devices
|
21 CFR 809 - In-Vitro Diagnostic Products
|
21 CFR 810 - Medical Device Recall Authority
|
21 CFR 812 - Investigational Device Exemptions
|
21 CFR 814 - Premarket Approval of Medical Device
|
21 CFR 820 - Quality System Regulations
|
21 CFR 820 - Quality System Regulations-ENGLISH/SPANISH
|
21 CFR 820 - Quality System Regulations-SPANISH
|
21 CFR 820 with Medical Device QSIT Manual
|
21 CFR Part 117 - Food GMPs
|
21 CFR 1270 - Human Tissue Intended for Transplantation
|
21 CFR 1271 - Human Cells, Tissues, Cellular and Tissue…
|
21 CFR 1270, 1271 - Cell Tissue
|
503B Compounding and Packaging
|
510k and PMA Guidelines
|
Canadian GMP Guidelines GUI-0001 2018
|
Chinese GMPs -SFDA - State Food & Drug Administration P.R. CHINA
|
Clinical Master Reference Guide
|
Dietary Supplement Master Handbook
|
Electronic Systems Master Handbook 1
|
EU and US GMPs with Annex 1
|
EU and US GMPs with Annexes 11 and 15
|
EU and US GMPs with ICH Q7, Q8(R2), Q9, Q10
|
EU and US GMPs with Q7 API
|
EU GMPs Chapter 1 - 9
|
EU GMPs with Annex 1 Sterile Medicinal Products
|
EU GMPs with Annex 10 Inhalation Products
|
EU GMPs with Annex 11 Computerized Systems
|
EU GMPs with Annex 11, 15 - Computerized Systems and Validation
|
EU GMPs with Annex 11, 15, 16 and ICH Q7
|
EU GMPs with Annex 11, 15, 16, 18, 19
|
EU GMPs with Annex 12 Ionizing Radiation
|
EU GMPs with Annex 13 Investigational medicinal Products
|
EU GMPs with Annex 14 Human Blood or Plasma Products
|
EU GMPs with Annex 15 Qualification and Validation
|
EU GMPs with Annex 16 Qualified Person and Batch Release
|
EU GMPs with Annex 17 Parametric Release
|
EU GMPs with Annex 19 Reference and Retention Samples
|
EU GMPs with Annex 2 Biological
|
EU GMPs with Annex 3 RadioPharma
|
EU GMPs with Annex 4 Vet. products other than Immuno
|
EU GMPs with Annex 5 Immunolgical Vet. Products
|
EU GMPs with Annex 6 Manufacture of Medicinal Gases
|
EU GMPs with Annex 7 Manufacture of Herbal Medicinal Products
|
EU GMPs with Annex 8 Sampling of Starting and Packaging Materials
|
EU GMPs with Annex 9 Manufacture of Liquids, Creams and Ointments
|
EU GMPs with ICH Q7
|
EU GMPs with ICH Q7, Q8(R2), Q9 and Q10
|
Eudralex - Pharmacovigilance for Medical Products Volume 9a
|
FDA DEA GMP Master Reference Guide
|
GLP Master Handbook
|
GMP - PAT Handbook
|
GMP International Master Reference Guide
|
GMP Medical Device Master Reference Guide
|
ICH E2A - Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
|
ICH E4 - Dose-Response Information to Support Drug Registration
|
ICH E6(R2) - Good Clinical Practice
|
ICH E8 - General Considerations for Clinical Trials
|
ICH M3(R2) - Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials
|
ICH Q10 - Pharmaceutical Quality System
|
ICH Q1A(R2) - Stability Testing of New Drug Substances and Products
|
ICH Q1E - Evaluation of Stability Data
|
ICH Q2(R1) - Validation of Analytical Procedures: Text and Methodology
|
ICH Q5E - Comparability of Biotechnological/Biological Products Subject to Changes
|
ICH Q7 with Q7 Auditors Check List
|
ICH Q7, Q8(R2), Q9 and Q10 Combination
|
ICH Q7, Q8(R2), Q9 and Q10 with FAQ
|
ICH Q7, Q8, Q9, Q10 and Q11
|
ICH Q8(R2) - Pharmaceutical Development
|
ICH Q9 - Quality Risk Management
|
ICH S2(R1) - Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
|
ICH S6 - Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
|
ICH S7A - Safety Pharmacology Studies for Human Pharmaceuticals
|
In Vitro Diagnostics 98/79/EC Medical Devices
|
In Vitro Diagnostics Master Handbook
|
Japanese GMP for Drugs and Quasi-drugs - 2005
|
Medical Device Clinical with EU Directive
|
Medical Device Combination 2
|
Medical Device QSIT Manual with 11 and 820
|
Medical Device QSIT Manual with 11, 803, 806, 820 and 821
|
Medical Device Quality Systems Manual with 11, 210/211, 820 and QSR Audit Checklist
|
Medical Device Quality Systems Manual with 11, 820, QSR Audit Checklist, 7382.845 with QSIT
|
Medical Device Quality Systems Manual with 820 and QSR Audit Checklist
|
Title 21 CFR Parts 1 - End Nine Volume Set
|
US and Canadian GMPs with ICH Q7, Q8(R2), Q9, Q10
|
US, EU and Canadian Medical Device Combination
|
US, EU and Japanese GMPs
|
VICH GL9 Animal GCP
|
Canadian - SOR98-282 Medical Devices Regulations
|
|
|